California Public Employees Retirement System’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
RI
RG
EAM
VA
ACP
California Public Employees Retirement System's CLDX Position: Q2 2021 in Review
California Public Employees Retirement System sold out of Celldex Therapeutics (CLDX) in Q2 2021, closing a stake of 78,426 shares — an estimated $1.62M sold.
California Public Employees Retirement System first reported a position in CLDX in Q2 2013 and held it in 32 quarters. The position peaked at $8.05M in Q3 2013. 131 funds tracked by Wall St. Rank hold CLDX as of Q2 2021.
- California Public Employees Retirement System reported no remaining Celldex Therapeutics position as of Q2 2021 after selling out during the quarter.
- California Public Employees Retirement System sold 78,426 Celldex Therapeutics shares in Q2 2021, an estimated $1.62M.
- California Public Employees Retirement System first reported a position in Celldex Therapeutics in Q2 2013 and held it in 32 quarters.
- California Public Employees Retirement System's Celldex Therapeutics position peaked at $8.05M in Q3 2013.
- 131 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2021.
Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.